Loading organizations...
Loading organizations...
Drug discovery for selective HDAC6 inhibitors treating axonopathies.
Augustine Therapeutics has raised $114.3M across 3 funding rounds.
Augustine Therapeutics has raised $114.3M in total across 3 funding rounds.
Augustine Therapeutics has raised $114.3M in total across 3 funding rounds.
Augustine Therapeutics's investors include Clara Campàs, Annette Clancy, Marie Schroeder, Asabys Partners.
Augustine Therapeutics has raised $114.3M across 3 funding rounds. Most recently, it raised $91.4M Series A in March 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 24, 2025 | $91.4M Series A | Clara Campàs, Annette Clancy, Marie Schroeder | |
| Jun 26, 2024 | $18.2M Series A | Asabys Partners | |
| Dec 16, 2019 | $4.7M Seed |